April 14, 2020
Authored and Edited by Safiya Aguilar; Samhitha M. Medatia; Elizabeth D. Ferrill
In Nevro Corp. v. Boston Scientific Corp., the Federal Circuit vacated the district court’s determination that various claims were invalid as indefinite under 35 U.S.C. § 112.
At the district court, defendant argued that certain claims were invalid under § 112 because infringement could only be determined after using the alleged infringing device or method. Defendant further argued that the specification failed to explain how to achieve the claimed therapeutic result with reasonable certainty and that the claims were susceptible to different interpretations.
On appeal, the Federal Circuit determined that the district court failed to apply the correct test for indefiniteness and held that the appealed claims were not indefinite under § 112. Applying Nautilus, the Court found that the specification was sufficient to inform a skilled artisan, with reasonable certainty, as to the scope of each of the contested claim terms. Defendant’s argument that a potential infringer might be unable to determine whether a particular device or act constituted infringement until after using the device or performing the act, was irrelevant to the indefiniteness analysis. As to Defendant’s argument that certain claim terms were indefinite because they were susceptible to different constructions, the Court affirmed that a claim does not fail for indefiniteness solely because it is susceptible to different constructions.
Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.